It's ironic given the initial hype was concerning the dangers of drugs from trangenic animals were initially branded frankenanimals and frankendrugs.
Frankenfungi doesn't have the same sort of ring to it.
Hey, I think it was all a few fringe groups trying to stir up controversy.
I think GTC will do OK, but in this sort of market, I hope they partner up with someone that can affort the research, getting money out of the market with stock offerings now days is going to be tough.
Good luck with GTC and I will be watching to see who they may get as a partner. Can't be that hard, even INGN was able to get $20 million out of Colgate. Which surprised me but the market didn't seem to care that much.
Thanks to all for putting up with some of my naive questions.